APSC2025

Program Overview

Program at a Glance

Program at a Glance (Tentative)

Program

Pre-Congress Workshops - September 12

Day 1 - September 13

Day 2 - September 14

Day 3 - September 15

Hybrid International Neurovascular Technical course 

Pre-Congress Workshops - September 12

  • Stroke Treatment Workshop
    (Collaboration with Japanese Society of Neuroendovascular Treatment)
  • Vascular Anatomy Workshop
    (Collaboration with Japanese Society of Neuroendovascular Treatment)
  • Neurosonology examination
  • Neurosonology Workshop
  • Bypass Hands-on Course
  • Endovascular Hands-on Course

Day 1 - September 13

8:30-9:00 Opening Ceremony and Welcome Session Main Hall

9:00-10:00 Plenary Session 1: Presidential Symposium Main Hall

Chairs: Shinichiro Uchiyama Japan
Byung-Woo Yoon Republic of Korea
Jeyaraj Pandian India

PL1-1

Jeyaraj Pandian

India

WSO's Strategic Vision for Combating Stroke Globally

PL1-2

NV Ramani

Singapore

Disparities in Stroke Burden in the Young in the Asia-Pacific Region

PL1-3

Shigeru Fujimoto

Japan

Initiatives and Future Plans of the Japan Stroke Society

10:50-12:20 Session 01: Controversies in Stroke Thrombectomy Main Hall

Chairs: Bernard Yan Australia
Shinichi Yoshimura Japan

S01-1

Marios Psychogios

Switzerland

Distal Arterial Occlusion: Results of Recent RCTs

S01-2

Bernard Yan

Australia

Stroke Thrombectomy for patients with pre-existing morbidity

S01-3

James R Caldwell

New Zealand

Treatment of acute LVO due to ICAD

S01-4

Huo Xiaochuan

China

Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy (ANGEL-TNK)

10:50-12:20 Session 02: Post-Stroke Rehabilitation A Hall

Chairs: Nam-Jong Paik Republic of Korea
Kazuhisa Domen Japan

S02-1

Kazuhisa Domen

Japan

Constraint-induced Movement Therapy

S02-2

Norhayati Hussein

Malaysia

Evidence-based Review of Stroke Rehabilitation

S02-3

Areerat Suputtitada

Thailand

Applications of TMS in Stroke Rehabilitation

S02-4

Nam-Jong Paik

Republic of Korea

Robot Assisted Stroke Rehabilitation

10:50-12:20 Session 03: Nursing Care B Hall

Chairs: TBD Australia
Lily Wong Singapore

S03-1

Mick Yu

Hong Kong

Role of Stroke Nurse in Hyperacute Stroke Management

S03-2

Yasuko Higuchi

Japan

Learning from Nursing a Patient Who Suffered a Stroke During Cancer Drug Therapy

S03-3

TBD

Australia

S03-4

Lily Wong

Singapore

Stroke Care: From ED to recovery

12:30-13:30 Luncheon Seminars (Including the Japanese lunch box)

Luncheon Seminar 1: Thrombectomy with Tigertriever Main Hall

sponsored by KANEKA MEDIX CORPORATION

Chair: Yuji Matsumaru Japan

LS1-1

Erez Nossek

USA

The advantages of Active Technologies for Neuro Interventions

LS1-2

Edgar Samaniego

USA

Tigertriever for ICAD and stentplasy

Luncheon Seminar 2: An Anti-Aβ Monoclonal Antibody Therapy for Early Alzheimer’s Disease A Hall

sponsored by Eisai Co., Ltd.

Chair: Masafumi Ihara Japan

LS2-1

Akihiro Kitamura

Japan

Clinical Management of Alzheimer’s Disease in the Era of Anti-Aβ Monoclonal Antibody Therapies - Learning from the Past and Embracing a Paradigm Shift -

LS2-2

Satoshi Saito

Japan

Lacanemab in Early Alzheimer's Disease: Real-World Data from a Single Center

Luncheon Seminar 3: An integrated AIS solution featuring pRESET and Esperance B Hall

sponsored by Shanghai Wallaby Medical Technologies Co., Inc.

Chair: Kenji Sugiu Japan

LS3-1

Ho Jun Yi

Republic of Korea

Thrombectomy device pRESET. Korean experience

LS3-2

Hirotaka Okumura

Japan

Advanced Clot-Capture Strategies with pRESET: Push it, Helicalize it, Swing it, Catch it

Luncheon Seminar 4: Thrombectomy C Hall

sponsored by Johnson & Johnson K.K.

Chair: Tetsu Satow Japan

LS4-1

Sarah Power

Ireland

Large bore catheter aspiration science

LS4-2

Yosuke Akamatsu

Japan

Transradial neurointervention using 8Fr balloon guide catheter

13:40-15:10 Session 04: Intracranial Atherosclerotic Disease Main Hall

Chairs: Nijasri C Suwanwela Thailand
Vignan Yogendrakumar Canada

S04-1

Arvind Sharma

India

Clinical and Imaging Biomarkers of ICAD Recurrence and Outcome

S04-2

Sarah Power

Ireland

Novel ICAD Imaging

S04-3

Bin Xu

China

Bypass for ICAD

S04-4

Edgar A Samaniego

USA

A New Method of Angioplasty for ICAD

13:40-15:10 Session 06: Brain and Heart B Hall

Chairs: Soon Chan Kwon Republic of Korea
Shigeru Fujimoto Japan

S06-1

Andrew Wong

Australia

Atrial Cardiopathy and Stroke -New Evidence-

S06-2

Yohanna Kusuma

Indonesia

Ultrasound Evaluation of Cardiogenic Stroke

S06-3

Takanao Mine

Japan

Diagnosis and Treatment of Atrial Fibrillation

S06-4

Ryuki Chatani

Japan

Advances in Left Atrial Appendage Closure: Redefining Stroke Prevention Strategies

16:00-17:30 Session 07: Novel Therapeutics for Intracerebral Hemorrhage (ICH) Main Hall

Chairs: Byung-Woo Yoon Republic of Korea
Ku-Chou Chang Taiwan

S07-1

Byung-Woo Yoon

Republic of Korea

Emerging Therapeutics in ICH

S07-2

Ivy Sung

Taiwan

Neutralization of Antithrombotic Drug in ICH

S07-3

Joonho Chung

Republic of Korea

Surgical Approaches to ICH

S07-4

Craig Anderson

Australia

Blood Pressure Management for ICH

16:00-17:30 Session 08: Stroke and Cognition A Hall

Chairs: Wing Chi Fong Hong Kong
Yusuke Yakushiji Japan

S08-1

Yoshiaki Itoh

Japan

Recent Advances in the Clinical Management of Cerebral Amyloid Angiopathy

S08-2

Masafumi Ihara

Japan

Treatment of Alzheimer's Disease - Hemorrhagic Side Effect

S08-3

Chaur-Jongh Hu

Taiwan

Post-Stroke Cognitive Function

S08-4

Hsin-Hsi Tsai

Taiwan

Small Vessel Disease

16:00-17:30 Session 09: Prevention of Stroke and Antithrombotics B Hall

Chairs: Sun U Kwon Republic of Korea
Phyu Phyu Lay Myanmar

S09-1

Zarni Myint Shwe

Myanmar

Primary and Secondary Prevention using Antiplatelets

S09-2

Keun Sik Hong

Republic of Korea

Early Anticoagulation after Ischemic Stroke

S09-3

Masatoshi Koga

Japan

Timing of (Re) initiation of Anticoagulation After Intracranial Hemorrhage.

S09-4

Yukiko Enomoto

Japan

Perioperative antiplatelet therapy for neuro-endovascular treatment

Day 2 - September 14

8:00-9:00 Morning Seminars (Including breakfast)

Morning Seminar 1: Smart Design, Better Outcomes: The Clinical Value of Solitaire™ X Main Hall

sponsored by Medtronic Japan Inc.

Chair: Ryushi Kondo Japan

MS1-1

Taichiro Imahori

Japan

Utilizing the Overlap Structure of Solitaire™ X

MS1-2

Naoki Kaneko

USA

Maximizing Safety and Efficacy with Solitaire™ by Leveraging the Structural Features of the Solitaire™

Morning Seminar 2: Imaging solution A Hall

sponsored by Siemens Healthcare K.K.

Chair: Manabu Shirakawa Japan

MS2-1

Chun Yuan

USA

MRI vessel wall imaging and its clinical applications and challenges

MS2-2

Hideaki Shigematsu

Japan

Clinical Utility of NAEOTOM Alpha in the Management of Stroke

9:00-10:00 Plenary Session 2: Debate - Thrombectomy for Distal Artery Occlusion: Pros and Cons Main Hall

Chairs: Marios Psychogios Switzerland
Kazunori Toyoda Japan

PL2-1

Erez Z Nossek

USA

Thrombectomy for Distal Occlusion: The Case for Intervention

PL2-2

Richard Li

Hong Kong

Thrombectomy for Distal Occlusion: The Case Against Intervention

PL2-3

Shinichi Yoshimura

Japan

Ongoing RCTs for Distal Artery Occlusion

10:50-12:20 Session 10: Reducing Post-Stroke Death and Disability Main Hall

Chairs: Maria Epifania Collantes Philippines
Teruyuki Hirano Japan

S10-1

Takayuki Nakagomi

Japan

Current status and perspective of post-stroke therapy utilizing regionally activated injury/ischemia-induced stem cells

S10-2

Tsong-Hai Lee

Taiwan

Pharmacological Interventions to Improve Stroke Recovery

S10-3

Jeyaraj Pandian

India

Alternative and Complementary Medicine

S10-4

Areerat Suputtitada

Thailand

Advances in Stroke Rehabilitation

10:50-12:20 Session 11: Stroke-Related Diseases A Hall

Chairs: Henry Ma Australia
Gamini Pathirana Sri Lanka

S11-1

P. Vijaya

India

Vasculitis and Immune-Related Stroke

S11-2

Hiroyuki Kawano

Japan

Stroke and Cancer

S11-3

Udaya Ranawaka

Sri Lanka

Stroke and Frailty

S11-4

Henry Ma

Australia

Stroke Associated Pneumonia: Update and future direction

10:50-12:20 Session 12: Cerebral Aneurysm Treatment B Hall

Chairs: Samuel Lam Hong Kong
Akira Ishii Japan

S12-1

Jung Hyun Park

Republic of Korea

Flow diverter treatment for bifurcated aneurysms - personal experience

S12-2

Hyun Seung Kang

Republic of Korea

Intrasaccular Devices for Aneurysmal Treatment

S12-3

Naoki Kaneko

USA

Future Endovascular Devices

S12-4

Hirofumi Nakatomi

Japan

Future perspective of intracranial aneurysm management

12:30-13:30 Luncheon Seminars (Including the Japanese lunch box)

Luncheon Seminar 5: Cerebral aneurysm treatment in Korea and Japan Main Hall

sponsored by Stryker Japan K.K

Chair: Toshiyuki Fujinaka Japan

LS5-1

Jung Hyun Park

Republic of Korea

FDS treatment trends in Korea and personal experience with Target Tetra and Surpass Evolve

LS5-2

Hajime Nakamura

Japan

Neurovascular intervention in Japan "Coil and FDS"

Luncheon Seminar 6: W-EB A Hall

sponsored by Terumo Corporation

Chair: Akira Ishii Japan

LS6-1

Hyun Seung Kang

Republic of Korea

Koran W-EB Registry: Treatment Outcomes of Woven EndoBridge

Luncheon Seminar 7: AIS (Mevo) B Hall

sponsored by MEDICO’S HIRATA INC.

Chair: Tsuyoshi Ota Japan

LS7-1

Marios-Nikos Psychogios

Switzerland

Future of DMVO management & experience of RED43/62 with Quattro-ADAPT Technique

Luncheon Seminar 8: Do antithrombotic agents require a dosage tailored for Japanese patients? C Hall

sponsored by Daiichi Sankyo Co., Ltd.

Chair: Teruyuki Hirano Japan

LS8-1

Shigeru Fujimoto

Japan

P2Y12 inhibitor

LS8-2

Masahiro Yasaka

Japan

DOAC

Luncheon Seminar 9: Shifting Paradigms: Role of Tenecteplase in Acute Ischemic Stroke D Hall

sponsored by Gennova Biopharmaceuticals Limited

Chair: Henry Ma Australia

LS9-1

Mark W Parsons

Australia

The Story of Tenecteplase in Stroke

LS9-2

Alejandro Bimbo F. Diaz

Philippines

Thrombolysis with Tenecteplase in Stroke Patients in Philippines

13:40-15:10 Session 13: Thrombolysis (Sponsored by T-FLAVOR) Main Hall

Chairs: Wing Chi Fong Hong Kong
Teruyuki Hirano Japan

S13-1

Mark W Parsons

Australia

The Steps leading to Approval of Tenecteplase

S13-2

Shuya Li

China

Tenecteplase Development in Asia

S13-3

Kazunori Toyoda

Japan

Trial for Tenecteplase Approval in Japan

S13-4

Jeyaraj Pandian

India

Future Global Perspectives on Thrombolysis

13:40-15:10 Session 14: Stroke and Gender A Hall

Chairs: Nijasri C Suwanwela Thailand
P. Vijaya India

S14-1

Maria Epifania Collantes

Philippines

Sex Hormone and Stroke

S14-2

Shaloo Singhal

Australia

Stroke in Pregnancy - a close look at the hypertensive disorders of pregnancy.

S14-3

VG Pradeep Kumar

India

Migraine-Related Stroke

S14-4

P. Vijaya

India

Reproductive Conditions and Their Treatment as Stroke Risk Factors

13:40-15:10 Session 15: Stroke and AI B Hall

Chairs: Zhang Meijuan China
Toshihiro Ishibashi Japan

S15-1

Beom Joon Kim

Republic of Korea

AI and Stroke Imaging

S15-2

Junichi Kouno

Japan

Prehospital AI Diagnosis of Stroke

S15-3

Thanh G Phan

Australia

Geospatial Analysis and Application: Planning Stroke Services in Large Scale

S15-4

Hiroyuki Takao

Japan

Applying AI to Neurological Deficits: Insights from Personal Experience

15:50-17:20 Session 16: Advancing Endovascular Treatments Main Hall

Chairs: Nobuyuki Sakai Japan
Hiroshi Yamagami Japan

S16-1

Erez Z Nossek

USA

New Devices for Thrombectomy

S16-2

Fumihiro Sakakibara

Japan

Clinical evidence of EVT for Chronic Subdural Hematoma

S16-3

Charles Matouk

USA

E-Shunt: A New Treatment for Hydrocephalus

S16-4

Lee Anne Slater

Australia

Decreased Pressure, Increased Awareness: A Spontaneous intracranial Hypotension pathway

15:50-17:20 Session 17: Local Challenges of Stroke Treatment in Asia-Pacific Countries A Hall

Chairs: NV Ramani Singapore
Hamidon Basri Malaysia

S17-1

Gamini Pathirana

Sri Lanka

Challenges in Stroke Treatment in Sri Lanka

S17-2

Cuong Tran Chi

Vietnam

Challenges in Stroke Treatment in Vietnam

S17-3

Kazutaka Uchida

Japan

Clinical Application of Prehospital IT Diagnostic Tool

S17-4

Wing Chi Fong

Hong Kong

Experience of Telestroke in Thrombolysis

15:50-17:20 Session 18: Vascular Malformations B Hall

Chairs: Joung-Ho Rha Republic of Korea
Amal Abou-Hamden Australia

S18-1

Yasunari Niimi

Japan

Endovascular treatment for head and neck vasular malformations

S18-2

Motoyuki Umekawa

Japan

Forefront of stereotactic radiosurgery for brain AVM and dural AVF

S18-3

Yasushi Matsumoto

Japan

Treatment of Cerebral AVM

S18-4

Naoya Kuwayama

Japan

Treatment of dural AVF

17:30-19:00 Plenary Session 3: WSO-APSO-JSS Symposium Main Hall

Chairs: NV Ramani Singapore
Shigeru Fujimoto Japan

PL3-1

Jeyaraj Pandian

India

WSO’s Global Stroke Center Certification: Raising Standards Worldwide

PL3-2

Craig Anderson

Australia

Challenges in Globalising Asian Stroke Research

PL3-3

Sun U Kwon

Republic of Korea

Genomics in the Diagnosis and Management of Stroke in Asia-Pacific

PL3-4

Kazunori Toyoda

Japan

Applicability of Treatments to Asia-Pacific populations

19:30-21:00 Gala Dinner Kobe Portopia Hotel

Day 3 - September 15

8:20-9:50 Session 19: Carotid Artery Stenosis Main Hall

Chairs: Chun Yuan USA
Kiyofumi Yamada Japan

S19-1

PN Sylaja

India

Substenotic Carotid Disease: Diagnosis and Management

S19-2

Kiyofumi Yamada

Japan

Symptomatic Carotid Web

S19-3

Manabu Shirakawa

Japan

Imaging Analysis of Carotid Artery Stenosis

S19-4

Charles Matouk

USA

T-CAR: A New Approach for Carotid Artery Stenosis

8:20-9:50 Session 20: Uncommon Causes of Stroke A Hall

Chairs: Richard Li Hong Kong
Yoshiaki Itoh Japan

S20-1

Angel Miraclin

India

Management of Cerebral Venous Sinus Thrombosis - Lessons learnt and the way forward

S20-2

Quentin Siu-hung LI

Hong Kong

Dissection

S20-3

Nijasri C Suwanwela

Thailand

Stroke and Genetics

S20-4

Satoru Miyawaki

Japan

Moyamoya disease: Genetic landscape and clinical implications

8:20-9:50 Session 21: Stroke Imaging B Hall

Chairs: Ba-Thang Nguyen Vietnam
Yuji Ueno Japan

S21-1

Vignan Yogendrakumar

Canada

Perfusion Imaging: When and How to Use It in AIS

S21-2

Soichiro Abe

Japan

CT Perfusion Parameters as Predictors of Symptomatic ICH After Mechanical Thrombectomy for LVO

S21-3

Hideaki Shigematsu

Japan

Stoke Imaging of Photon Counting CT

S21-4

Yohanna Kusuma

Indonesia

TCD in AIS Assessment

10:00-11:30 Late Breaking Session Main Hall

11:30-12:00 Closing Ceremony Main Hall

Sponsorship

Karger

PAGE TOP